Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064438
Filing Date
2025-05-06
Accepted
2025-05-06 16:05:35
Documents
74
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idya-20250331.htm   iXBRL 10-Q 1949211
2 EX-10.1 idya-ex10_1.htm EX-10.1 32315
3 EX-10.2 idya-ex10_2.htm EX-10.2 186343
4 EX-10.3 idya-ex10_3.htm EX-10.3 57911
5 EX-10.4 idya-ex10_4.htm EX-10.4 629415
6 EX-19.1 idya-ex19_1.htm EX-19.1 190007
7 EX-31.1 idya-ex31_1.htm EX-31.1 17664
8 EX-31.2 idya-ex31_2.htm EX-31.2 17238
9 EX-32.1 idya-ex32_1.htm EX-32.1 15083
  Complete submission text file 0000950170-25-064438.txt   9628972

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20250331.xsd EX-101.SCH 1238149
76 EXTRACTED XBRL INSTANCE DOCUMENT idya-20250331_htm.xml XML 1426811
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 25917203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)